IndraLab

Statements


USP19 activates MAP1LC3. 1 / 1
| 1

eidos
"In CSE-treated BEAS-2B cells , USP19 knockdown reduced FUNDC1 and LC3 II / I , increased the levels of TOM20 , improved cell survival , mitochondrial membrane potential , and OCR , and inhibited apoptosis ."